लोड हो रहा है...

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

Our objective was to clarify the heterogeneity in response to infliximab treatment in rheumatoid arthritis (RA); to this end, a bioassay was designed to explore the contribution of circulating tumour necrosis factor (TNF)-α bioactivity and its possible link to response. The bioassay is based on the...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Marotte, Hubert, Maslinski, Wlodzimierz, Miossec, Pierre
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2005
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064892/
https://ncbi.nlm.nih.gov/pubmed/15642135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1465
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!